Changes

Jump to navigation Jump to search
no edit summary
Line 9: Line 9:  
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]]
 
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]]
   −
==Mastocytosis==
+
==Mastocytosis ([[Mastocytosis|Overview Page Link]])==
    
*[[Cutaneous Mastocytosis]]
 
*[[Cutaneous Mastocytosis]]
Line 15: Line 15:  
*[[Mast Cell Sarcoma]]
 
*[[Mast Cell Sarcoma]]
   −
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2==
+
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])==
    
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
 
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
Line 22: Line 22:  
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
 
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
   −
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)==
+
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])==
    
*[[Chronic Myelomonocytic Leukemia (CMML)]]
 
*[[Chronic Myelomonocytic Leukemia (CMML)]]

Navigation menu